0001104659-21-134639.txt : 20211104
0001104659-21-134639.hdr.sgml : 20211104
20211104212946
ACCESSION NUMBER: 0001104659-21-134639
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211104
FILED AS OF DATE: 20211104
DATE AS OF CHANGE: 20211104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Intelligent Medicine Sponsor LLC
CENTRAL INDEX KEY: 0001885142
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41024
FILM NUMBER: 211382017
BUSINESS ADDRESS:
STREET 1: 9001 BURDETTE ROAD
CITY: BETHESDA
STATE: MD
ZIP: 20817
BUSINESS PHONE: 202-905-5834
MAIL ADDRESS:
STREET 1: 9001 BURDETTE ROAD
CITY: BETHESDA
STATE: MD
ZIP: 20817
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intelligent Medicine Acquisition Corp.
CENTRAL INDEX KEY: 0001850051
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 862283527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9001 BURDETTE RD.
CITY: BETHESDA
STATE: MD
ZIP: 20817
BUSINESS PHONE: 202-905-5834
MAIL ADDRESS:
STREET 1: 9001 BURDETTE RD.
CITY: BETHESDA
STATE: MD
ZIP: 20817
3
1
tm219664-17_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2021-11-04
0
0001850051
Intelligent Medicine Acquisition Corp.
IQMD
0001885142
Intelligent Medicine Sponsor LLC
9001 BURDETTE RD.
BETHESDA
MD
20817
0
0
1
0
Class B Common Stock
Class A Common Stock
4900000
D
As described in the issuer's registration statement on Form S-1 (File No. 333-260205) (the "Registration Statement") under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like) and subject to certain anti-dilution rights and have no expiration date.
The shares of Class B common stock beneficially owned by the reporting person include up to 675,000 shares subject to forfeiture to the extent the underwriter of the initial public offering of the issuer's securities does not exercise in full its over-allotment option as described in the Registration Statement.
/s/ Gregory C. Simon, Manager of Intelligent Medicine Sponsor LLC
2021-11-04